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It has been shown that the brain has its own intrinsic renin–angiotensin system (RAS) and angiotensin-
(1–7) (Ang-(1–7)) is particularly interesting, because it appears to counterbalance most of the Ang II
effects. Ang-(1–7) exerts its biological function through activation of the G-protein-coupled receptor
Mas. Interestingly, hippocampus is one of the regions with higher expression of Mas. However, the role
of Ang-(1–7)/Mas axis in hippocampus-dependent memories is still poorly understood. Here we demon-
strated that Mas ablation, as well as the blockade of Mas in the CA1-hippocampus, impaired object rec-
ognition memory (ORM). We also demonstrated that the blockade of Ang II receptors AT1, but not AT2,
recovers ORM impairment of Mas-deﬁcient mice. Considering that high concentrations of Ang-(1–7) may
activate AT1 receptors, nonspeciﬁcally, we evaluate the levels of Ang-(1–7) and its main precursors Ang I
and Ang II in the hippocampus of Mas-deﬁcient mice. The Ang I and Ang II levels are unaltered in the
whole hipocampus of MasKo. However, Ang-(1–7) concentration is increased in the whole hippocampus
of MasKo mice, as well as in the CA1 area. Taken together, our ﬁndings suggest that the functionality of
the Ang-(1–7)/Mas axis is essential for normal ORM processing.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
It is well established that renin–angiotensin system (RAS) is one
of the major systems in the regulation of cardiovascular function
and ﬂuid homeostasis. Furthermore, it has been shown that the
brain has its own intrinsic RAS with most of all its components ex-
pressed in the central nervous system (von Bohlen und Halbach &
Albrecht, 2006). Interestingly, the constituents of RAS expression
are not restricted to the brain areas involved in the control of car-
diovascular functions. RAS components are also expressed in brain
regions involved in the processing of cognitive functions, like hip-
pocampus (Chappell, Brosnihan, Diz, & Ferrario, 1989; Sirett, Bray,
& Hubbard, 1981) and amygdala (Krizanova, Kiss, Zacikova, &
Jezova, 2001; Von Bohlen und Halbach, Walther, Bader, & Albrecht,
2000; Yang & Raizada, 1999).
The majority of investigations about RAS role on the central ner-
vous system (CNS) focus on angiotensin II (Ang II), considered the
most important angiotensin peptide. When administered centrally,rociências, Departamento de
niversidade Federal de Minas
Pampulha, 31270-901 Belo
sevier OA license.Ang II can either improve (Braszko, 2002; Braszko & Wisniewski,
1988) or impair memory (Bonini et al., 2006; Kerr et al., 2005).
Regarding synaptic plasticity, Ang II blocks long-term potentiation
(LTP) in the hippocampus (Armstrong, Garcia, Ma, Quinones, &
Wayner, 1996; Denny, Polan-Curtain, Wayner, & Armstrong,
1991) and amygdala (von Bohlen und Halbach & Albrecht, 1998).
Moreover, Ang II reduces NMDA receptors signaling through AT2
(angiotensin II receptor type 2) receptors-mediated mechanisms
(Jing, Grammatopoulos, Ferguson, Schelman, & Weyhenmeyer,
2004; Schelman, Kurth, Berdeaux, Norby, & Weyhenmeyer, 1997;
Schelman et al., 2004).
Another angiotensin peptide broadly studied is the angiotensin
IV (Ang IV), which is the biologically active (3–8) fragment of Ang II
(De Bundel, Smolders, Vanderheyden, & Michotte, 2008). Acute
intracerebroventricular (i.c.v.) administration of Ang IV or its ana-
log Nle1-Ang IV improves the performance of rats in a range of
learning and memory tasks including passive avoidance (Braszko
&Wisniewski, 1988), object recognition (Braszko, 2004), spontane-
ous alternation (De Bundel et al., 2009) and Barnes maze (Lee et al.,
2004). In addition, Ang IV induces facilitation of LTP in CA1 area of
the hippocampus (Kramar et al., 2001).
The action of angiotensin peptides on the brain is not limited to
Ang II and IV. Several other angiotensins are recognized as being
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because it appears to counterbalance most of the Ang II effects
(Daemen, Lombardi, Bosman, & Schwartz, 1991; Strawn, Ferrario,
& Tallant, 1999; Tallant, Ferrario, & Gallagher, 2005). For example,
while Ang II blocks LTP, Ang-(1–7) appears to enhance LTP in the
hippocampus (Walther et al., 1998).
The biological relevance of Ang-(1–7) has been reinforced by
the identiﬁcation of its receptor, the G-protein-coupled receptor
Mas (Santos et al., 2003). The physiological function of the Ang-
(1–7)/Mas axis has been supported, at least in part, by studies
using the Mas-deﬁcient mice (MasKo). The MasKo, on the mixed
129/C57BL/6 genetic background, showed higher anxiety com-
pared to the controls, but no alterations were found in the Morris
Water Maze task (Walther et al., 1998).
To further explore the effect of Mas ablation on learning and
memory, we use MasKo in the FVB/N background and chose four
different memory behavioral tasks: step-down inhibitory avoid-
ance task, Y-maze and two distinct protocols of the object recogni-
tion (novelty and the spatial location of the objects). The choice of
tasks encompass a broad spectrum of memory related processes
(fear-related memory, immediate working memory and declara-
tive-like memory) while, at least to some extent, recruiting areas
known to express strong labeling for Mas. The Mas receptors are
expressed in several brain regions: abundant in hippocampus
(Martin, Grant, & Hockﬁeld, 1992); the olfactory tubercle (medial
part), the piriform cortex, olfactory bulb, amygdala, anterodorsal
thalamic nucleus, hypoglossal nucleus; nucleus of the solitary
tract, caudal and rostral ventrolateral medulla, inferior olive, parvo
and magnocellular portions of the paraventricular hypothalamic
nucleus, supraoptic nucleus, and lateral preoptic area (Becker,
Etelvino, Walther, Santos, & Campagnole-Santos, 2007); while a
weak to moderate labeling was present all over the neocortex
and especially in the frontal lobe (Bunnemann et al., 1990).
The distinct behavioral tasks chosen have been demonstrated to
involve the hippocampus as part of the neural circuitry underling
memory processing. The well established, hippocampal-depen-
dent, one-trial, step-down inhibitory avoidance task (Bekinschtein
et al., 2007; Bekinschtein et al., 2010; Bernabeu et al., 1995;
Bevilaqua, Kerr, Medina, Izquierdo, & Cammarota, 2003; Cammaro-
ta et al., 1995; Cammarota et al., 2008; Izquierdo et al., 2006; Ros-
sato et al., 2006) was used to access fear-related memory. The
spontaneous alternation behavior was accessed through the Y-
maze, which is considered a hippocampal-dependent immediate
working memory task (Carroll et al., 2007; de Castro et al., 2009;
Hughes, 2004; King & Arendash, 2002a, 2002b; Pych, Kim, & Gold,
2006; Rosario, Ramsden, & Pike, 2006). Finally, we use two distinct
protocols of the object recognition task to verify the effect of Mas
ablation on declarative-like memory (Dere, Huston, & De Souza Sil-
va, 2005, 2007). The two protocols evaluate distinct components of
the recognition memory, the novelty and the spatial location of the
objects (Barker, Bird, Alexander, & Warburton, 2007; Dere et al.,
2005). There are studies showing that these protocols may require
the hippocampus and other cortical structures, specially the perih-
inal cortex, differently (Winters, Forwood, Cowell, Saksida, &
Bussey, 2004), please see also (Dere et al., 2007). In summary,
two ORM tasks were chosen in order to perform a more compre-
hensive evaluation both in terms of the memory components and
the neural substrates involved.
Furthermore, we took advantage of the speciﬁc Mas antagonist,
A-779 (Santos et al., 1994), to verify the effect of the blockade of
Mas in the hippocampus on the consolidation of the object recog-
nition memory (ORM).
Considering that RAS encompasses different biologically active
peptides, with a common precursor, the genetic absence of one
component could unbalance the already complex interactions be-
tween the various angiotensins (reviewed by von Bohlen undHalbach & Albrecht, 2006). In fact, Ang-(1–7), in spite of its low
afﬁnity to AT1 and AT2 receptors, can produce nonspeciﬁc activa-
tion of AngII receptors (Rowe, Saylor, Speth, & Absher, 1995). Hell-
ner and coworkers (2005) demonstrated that Ang-(1–7)-induced
suppression of hippocampal-LTP in MasKo mice is mediated by a
non-speciﬁc action of Ang-(1–7) on AT1 receptors. Thus, in order
to further clarify the neurochemical basis of the ORM deﬁcit in
MasKo mice, we decided not only to quantify the levels of Ang-
(1–7) and its main precursors (Ang I and Ang II), but also to evalu-
ate the involvement of Ang II receptors in the memory processes.2. Materials and methods
2.1. Subjects
Eight to 10 week-old MasKo_FVB/N mice (Alenina, Xu,
Rentzsch, Patkin, & Bader, 2008) and age-matching FVB/N mice
were used in the study. Animals were housed in groups of three
to ﬁve per cage in a temperature-controlled room (22 ± 2 C) with
a 12:12 light–dark cycles. Food and water were provided ad libi-
tum. All experimental procedures were carried out in the light
phase.
All experiments were conducted according to National Insti-
tutes of Health guidelines for animal care. The protocols used here
were approved by the Animal Care and Use Committee at the Fed-
eral University of Minas Gerais, Brazil (167/2008). The investiga-
tors were blind to the genotype of the mice during all
experiments procedures.2.2. Behavioral assessment tests
In order to suggest that a given biochemical system plays a role
in learning and memory using mutant animals, it is imperative to
show that these animals do not have any behavioral impairment
that could account for the cognitive deﬁcit (or improvement) ob-
served. Thus, besides the proper intrinsic controls to all cognitive
tasks evaluated, additional three other behavioral assessment tests
were conducted: (a) Wire hang test (motor strength impairment);
(b) Sticky paper test (somatosensory and proprioceptive percep-
tion) and (c) Visual placing response (visual depth impairment).
The wire hang test seeks to evaluate motor strength deﬁcits in
rodent models of central nervous system disorders. The test is de-
scribed in detail elsewhere (Sango et al., 1996). In summary, the
mouse is placed on the top of a wire cage lid (22 cm  22 cm)
and then, once the investigator is sure to cause the animal to grip
the wires, the lid is turned upside down. The latency until the
mouse falls off the lid is quantiﬁed (up to a cutoff time of 60s).
The sticky paper test evaluates possible somatosensory impair-
ments. We used the protocol described by Metz and Schwab
(2004). Self-adhesive backed labels (0.7  1.1 cm) were placed
onto the ventral side of the distal hind limb. Immediately, the ani-
mal was put into an arena (50  50  50 cm) and the latency for
the ﬁrst reaction to the stimulus (e.g. paw lifting, snifﬁng, biting,
or removal) was recorded. The visual placing response tests the
integrity of the visual sensory system and visual depth impair-
ments. The test consists of suspending the mouse by its tail while
slowly lowering the animal towards a solid surface, without ever
allowing direct contact of vibrissae to the surface (Fox, 1965; Metz
& Schwab, 2004). Response is rated according to a scoring system:
0 indicates no observable placing response 1 represents a weak
placing response and a score of 2 points reﬂects a clear placing
reaction (the head raises and forelimbs extend towards the sur-
face). For all behavioral evaluation tests conducted, the indepen-
dent Student’s t test was used to compare means between
genotypes. Results are presented as mean ± SD.
T.L.N. Lazaroni et al. / Neurobiology of Learning and Memory 97 (2012) 113–123 1152.3. Inhibitory avoidance
The apparatus was a Plexiglas box (21  22.5  22.5 cm) with a
10 cm2 acrylic platform on the left end of a series of steel bars
(diameter 0.4 cm), spaced 0.6 cm apart, designed for use in mice,
that made up the ﬂoor of the box (Insight Equipamentos, Ribeirão
Preto, Brazil). For training, animals were gently placed on the plat-
form facing the left rear corner of the box. When they stepped
down and placed their four paws on the grid, they received a 2 s,
0.3 mA, scrambled foot shock (Prado et al., 2006). There was no
habituation to the box. Mice are animals with innate high explor-
atory behavior thus having a very short step-down latency during
training.
Memory retention was evaluated in a non-reinforced test ses-
sion carried out at 1.5 h and 24 h to analyze short- (STM) and
long-term memory (LTM), respectively. Data were analyzed and
passed in the normality test, thus were expressed as mean ± SEM
and further analyzed by One-way ANOVA repeated measures fol-
lowing Tukey’s multiple comparison test.2.4. Y-maze
Immediate working memory performance was assessed by
recording spontaneous alternation behavior (SAB) during a single
session in the Y-maze (de Castro et al., 2009). Each mouse, new
to the maze (made in white wood with 30 cm long by 6 cm wide
by 20 cm high), was placed at the end of one arm and allowed to
move freely through the maze during an 8 min session. The
maze was positioned at the exact same location for all proce-
dures. The series of arm entries was recorded visually. An arm
choice was added only when both forepaws and hind paws fully
entered the arm. The maze was cleaned between experiments
with 70% alcohol to remove any residual odors. Alternation
was deﬁned if mice entered different arms three times in succes-
sion from the results of consecutive arm entering. The number of
overlapping entrance sequences (e.g. ABC, BCA) was deﬁned as
the number of alternations. The percentage alternation was cal-
culated according to the following formula: [total alternation/
(total arms entered  2)]  100. Therefore, the following hypo-
thetical sequence of arms entered by a mice: A, C, A, B, C, A,
C, B, A, C would yield an alternation score of 75% ([6 alterna-
tions/(10–2) arms entered]  100). Random selection of goal arms
yields an alternation score of 50%. We also analyzed the total
number of arm entries as an index of locomotor activity,
although it is not direct evidence. To determine if alternation
scores were signiﬁcantly above the chance (50%), we used one-
sample t test. To comparison between groups we use the inde-
pendent Student’s t-test.2.5. Elevated plus maze
Elevated plus maze is a method for the assessment of uncondi-
tioned anxiety-like behavior in rats and mice (Lister, 1987). The
apparatus consists of two open arms and two closed arms, crossed
in the middle perpendicularly to each other, and a center area. The
maze was raised 30 cm above the ﬂoor. Mice are allowed to move
freely between the arms during 5 min. The number of entries into
the open arms and the time spent in the open arms are used as
indices of open space-induced anxiety in mice (Voikar, Polus,
Vasar, & Rauvala, 2005). Subsequently, the percentage of visits, as
well as the percentage of time spent in the open arms was calcu-
lated. To comparison between groups we use the independent Stu-
dent’s t test.2.6. Object recognition
All animals were given a single 20 min habituation session in an
empty white plastic cage (50 cm  40 cm  20 cm); which was
equally illuminated and with no spatial/visual cues. Twenty-four
hours later, in the training session (TR) of the novel object recogni-
tion task (NOR), animals were allowed to explore two copies of an
identical object during 10 min. Memory retention was evaluated
during the test session (TT) carried out 1.5 h, to evaluate STM
and 24 h, to evaluate LTM. During test session, with duration of
10 min, one object was identical from TR and the second was an
object never before explored by the animal (Capettini, Moraes,
Prado, Prado, & Pereira, 2011).
At least 48 h after the LTM test in the NOR task, the same ani-
mals, except one MasKo mouse, were submitted to spatial object
recognition (SOR) (Dere et al., 2005). During the TR session, ani-
mals were allowed to explore two identical objects (distinct from
those used in the NOR) during 10 min. One hour later, during the
TT, one object was shifted to a novel location within the cage.
All objects (available in duplicate) presented similar material
and size, but distinct color and shape. The objects used had been
selected from a large pool of objects on the criterion that mice
would spend approximately equal amounts of time exploring each
of them (data not shown). Between trials, box and objects were
cleaned with 70% alcohol and air-dried. Exploration time was de-
ﬁned as snifﬁng or touching the object with the nose (Capettini
et al., 2011).
A digital camera was mounted on the ceiling above the box and
connected to a computer with a video-tracking system that objec-
tively monitored and quantiﬁed animals’ movements (ANY-maze –
Stoelting, Inc., Wood Dale, IL). The results are expressed as recogni-
tion index, RI, (time exploring the new object/total time exploring
objects). To analyze if animals spent signiﬁcantly more than 50% of
exploration time with the novel or new located object we use One-
sample t-test. This initial analysis is important to demonstrate that
the animals have better than chance performance otherwise, the
task does not measure object recognition memory. The RI values
above 0.5 mean that the animal recognized the new object or
new located object. To compare between groups, we used the inde-
pendent Student’s t-test (Fig. 2); one-way ANOVA (Fig. 3) or two-
way ANOVA (Fig. 4).
2.7. Intra-hippocampus drug injection protocol
FVB/N mice were bilaterally implanted, under deep ketamin
(70 mg/kg) and xylazine (10 mg/kg) anesthesia, with 26-gauge
guides aimed to the CA1 region of the hippocampus in accordance
to coordinates (DV 1.0; AP 1.94; LL 1.6) taken from the Mouse Brain
Atlas of Paxinos and Franklin (1997) (Fig. 3C). Animals were al-
lowed to recover for 4 days and then were submitted to the novel
object recognition task.
Immediately after training session on NOR, a 33-gauge cannula
was tightly ﬁtted into the implanted guide and linked by an acrylic
tube (P10) to a Hamilton micro syringe. Infusions (0.5 lL/side)
were carried out using an infusion pump (0.5 lL/min); the 33-
gauge cannula was left in place for 60 additional seconds to mini-
mize back ﬂow.
The drug used, A-779 ([D-Ala7]-ANG-(1–7), is a speciﬁc antago-
nist of Mas (Santos et al., 1994) and was administered in two dif-
ferent concentrations: 100 pmol and 500 pmol (Becker, Santos, &
Campagnole-Santos, 2005; Fontes, Martins Pinge, Naves, Campag-
nole-Santos, & Lopes, 1997; Zhou et al., 2010). After the injection,
the same animal were submitted to STM and LTM tests, 1.5 and
24 h, respectively.
Cannula placement was veriﬁed postmortem as described pre-
viously (Pereira et al., 2005). Brieﬂy, 2–4 h after the behavioral test,
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above and the extension of the dye 30 min thereafter was taken
as indicative of the presumable diffusion of the vehicle or drug pre-
viously given to each animal. Only data from animals with correct
cannula implants were included in statistical analyze. Data were
expressed and analyzed as explained in the object recognition sec-
tion, except the groups were compared by One-way ANOVA and
Bonferroni’s multiple comparison test.
2.8. Peripheral drug injection protocol
Losartan (Sigma–Aldrich) 10 mg/kg was administered by intra-
peritoneal (i.p.) injection, 18 h and 1 h prior training (Raghavendra,
Chopra, & Kulkarni, 2001). It is well accepted that this dose of
losartan crosses the brain blood barrier and functionally blocks
their targets in the brain (Polidori, Ciccocioppo, Pompei, Cirillo, &
Massi, 1996; Tota et al., 2009; Wang, Tan, & Leenen, 2003).
PD123319 (Sigma–Aldrich) 1 mg/kg was administered by sub-
cutaneous (s.c.) injection, 12 h and 1 h before training session
(Macova, Pavel, & Saavedra, 2009).
We did not observe any difference regarding i.p. and s.c. admin-
istration in the saline group (data not shown), then our saline
group is composed by both i.p. and s.c. saline injected mice.
Data were expressed as recognition index. After the one-sample
t-test analysis, as explained in Section 2.4, we performed the two-
way ANOVA with Bonferroni post-test. The interaction between
factors (treatment X genotype) was further analyzed by one-way
ANOVA or independent t-test.
2.9. Radioimmunoassay (RIA)
Hippocampus or only the CA1 area was harvested from each
animal and the samples were withdrawn into two different sets
of ice-cooled tubes, one containing 7.5% ethylenediaminetetraaci-
dic acid, EDTA, for total protein determination and the other
containing protease inhibitors cocktail (0.01 mmol/L p-hydroxy-
mercury benzoate; 1.5 mmol/L o-phenanthroline; 0.01 mmol/L
para-methyl sulphonil ﬂuoride; 0.05 mmol/L Pepstatin A, and
10 mmol/L EDTA) for angiotensin peptide measurements (50 lL
per 1 mL of sample). Samples were centrifuged at 2000  g for 20
min at 4 C, and the supernatant was stored at 20 C. Peptides
were extracted onto Bond-Elut phenylsilica cartridge (Varian,
USA). The columns were pre-activated by sequential washes with
10 ml of 99.9% Acetonitrile/0.1% heptaﬂuorobutyric acid (HFBA)
and 10 ml of 0.1% HFBA. Sequential washes with 10 ml of 99.9%
Acetonitrile/0.1% HFBA, 10 ml of 0.1% HFBA, 3 ml of 0.1% HFBA con-
taining 0.1% BSA, 10 ml of 10% HFBA and 3 ml of 0.1% HFBA were
used to activate the columns. After sample application, the col-
umns were washed with 20 ml of 0.1% HFBA and 3 ml of 20% HFBA.
The adsorbed peptides were eluted with 3 ml of 99.9% Acetonitrile/
0.1% HFBA into polypropylene tubes rinsed with 0.1% BSA. After
evaporation, Ang I, Ang II and Ang-(1–7) peptides levels were mea-
sured by radioimmunoassay (RIA) (Botelho, Block, Khosla, &
Santos, 1994). Proteins were quantiﬁed by the Bradford method
(Bradford, 1976). Student’s t-test was used to analyze the data.Fig. 1. MasKo mice exhibit normal inhibitory avoidance task (IA) memory, and
spontaneous alternation behavior (SAB) in the Y-maze, as well as behave like
control mice in the plus maze task. (A) Training, short- (STM) and long-term
memory (LTM) latencies for IA task. MasKo (n = 12) and FVB/N (n = 17) exhibit
signiﬁcant increased latency in both STM and LTM tests comparing to the training
session. Values are mean ± SEM. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.0001 comparing to the
training session in the same genotype. (B) SAB in the Y-maze. FVB/N (n = 20) and
MasKo (n = 19) exhibit signiﬁcant alternation above the chance (50%) and (C) there
was no difference between groups in the percentage of arms entered in the Y-maze.
There was no difference between genotype (n = 8) in both (D) time and entries (E) in
the open arms of the elevated plus maze. Values are mean ± SEM. ⁄P < 0.001;
⁄⁄P < 0.0001 comparing to 50%.3. Results
3.1. MasKo mice behave like FVB/N in the inhibitory avoidance,
Y-maze, and elevated plus maze tasks
To date, the knowledge about the MasKo mice performance in
hippocampus-dependent tasks is limited to the water maze
(Walther et al., 1998). Considering that Mas is highly expressed
in the hippocampus, we decided to determine if Mas ablation altersthe performance of mice in distinct hippocampus-dependent tasks.
To address this question, we evaluated FVB/N and MasKo mice,
backcrossed to the same genetic background (Alenina et al.,
2008), in the inhibitory avoidance (IA) and Y-maze tasks. We also
evaluated the anxiety-like behavior in the MasKo, since it was
demonstrated that on the mixed 129/C57BL/6 genetic background,
MasKo present higher anxiety compared to the controls (Walther
et al., 1998).
As shown in Fig. 1A, FVB/N (n = 12; F(2,22) = 8.54; P = 0.001) as
well as MasKo (n = 17; F(2,32) = 43.85; P < 0.0001) are able to asso-
ciate the platform step-down with the shock delivery, which is
demonstrated by the increase in the latency in both STM and
LTM tests, comparing to the training session. Furthermore, we
did not observe difference between genotypes regarding training
(t(27) = 0.59, P = 0.55), STM (t(27) = 1.45, P = 0.15) or LTM
(t(27) = 1.69, P = 0.10) latencies.
We also analyzed the spontaneous alternation behavior (SAB)
using the Y-maze. The above-chance levels of SAB reﬂect both a
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working memory (reviewed by Hughes, 2004). As shown in Fig. 1B,
both FVB/N (n = 20; t(19) = 5.38, P < 0.001) and MasKo (n = 19,
t(18) = 3.88, P = 0.001) were able to alternate above the chance
(50%) and there was no difference between groups in the number
of arms entered (t(37) = 1.1, P = 0.278) (Fig. 1C). Our results dem-
onstrated that Mas ablation has no effect on both IA and SAB.
Differentially to the MasKo on the mixed 129/C57BL/6 genetic
background, the MasKo on the FVB/N background did not present
anxiety-related behavior. As showed in the Fig. 1D and E, there
was no difference between genotypes regarding the percentage
of time (t(14) = 1.69, P = 0.11) or percentage of entries in the open
arms (t(14) = 0.55, P = 0.58).
3.2. MasKo mice show no evidence of behavioral impairment
The behavioral assessment tests (wire hang, sticky paper and vi-
sual placing response) showed no evidence of behavioral impair-
ment in MasKo mice. Motor strength evaluation, wire hang test,
did not differ among genotypes: FVB/N (n = 5) and MasKo (n = 5)
had latencies of 52 ± 17 s and 56 ± 7 s, respectively (t(8) = 0.54,
P = 0.59). The latency to the ﬁrst reaction to the adhesive backed
labels place under the mouse hind limb also showed no difference
between FVB/N (n = 6, 144 ± 52 s) and MasKo (n = 6, 159 ± 40 s)
animals (t(10) = 0.53, P = 0.6). In the visual placing response test,
all animals raised their heads and extended forelimbs towards
the surface (FVB/N, n = 6, and MasKo, n = 6, all presented a maxi-
mum score of 2).
3.3. MasKo mice have impaired novel and spatial object recognition
memories
Novel object recognition (NOR) is a form of visual paired com-
parison task that can be used to examine the role of the hippocam-
pus in memory storage (Clark, Zola, & Squire, 2000; Rossato et al.,
2007).
In a 1.5 h retention test, performed to examine short-term
memory (Fig. 2A, STM), FVB/N mice present recognition index
(RI) above 0.5 which indicates intact NOR memory (n = 10;
t(9) = 3.53, P = 0.006). However, MasKo mice were unable to recog-
nize the new object during the STM test session (n = 8; t(7) = 0.14,
P = 0.888). Furthermore, unpaired t-test revealed statistical differ-
ence between groups (t(16) = 2.502, P = 0.023).
Similar results were obtained in the 24-h retention test (Fig. 2A;
LTM). FVB/N mice showed intact NOR (n = 10; t(9) = 6.38,
P = 0.0001) while MasKo mice did not (n = 8; t(7) = 1.05, P = 0.32).
Moreover, there was statistical difference between genotypes
(t(16) = 2.38, P = 0.02). These results cannot be attributed to differ-Fig. 2. Impaired object recognition memories in MasKo mice. (A) Recognition indexes (R
recognize the new object while MasKo (n = 8) did not. (B) RI for spatial object location tas
place, but MasKo (n = 7) did not. Values are mean ± SEM. ⁄P < 0.05 indicates genotype efences in the total object exploration time during the training ses-
sion (data expressed as mean ± SD: FVB/N = 42.6 ± 15.5 s;
MasKo = 50.8 ± 16.6 s).
A modiﬁcation of the NOR paradigm, named spatial object rec-
ognition (SOR), allows measurement of the memory for spatial
locations within a familiar arena, where objects have been initially
explored (Dere et al., 2007). FVB/N mice recognized the object pre-
sented in a different position during the test session (n = 10;
t(9) = 3.054, P = 0.01), while MasKo show deﬁcit in this task
(n = 7; t(6) = 0.481, P = 0.64) (Fig. 2B). The comparison between
groups showed statistical difference in the SOR (t(15) = 2.437,
P = 0.02), with no difference regarding total object exploration time
during the training session (data expressed as mean ± SD: FVB/
N = 43.24 ± 20.67 s; MasKo = 47.82 ± 19.22 s). Our results showed
that both novel and spatial object recognition memories are im-
paired in MasKo mice.
3.4. Intra-hippocampus A-779 infusion impaired NOR
Our results demonstrated that not all hippocampus-dependent
memories are impaired in MasKo mice. In fact, we showed that
speciﬁcally object recognition memory is impaired in MasKo mice.
Based on this, and the fact that hippocampus presents high level of
Mas expression (Metzger et al., 1995; Young, O’Neill, Jessell &
Wigler, 1988), we investigate if the expression of ORM could be af-
fected by the Mas blockade, directly into the hippocampus. To ad-
dress this question we administered, in FVB/N mice, A-779
immediately post-training directly into the CA1 area of the hippo-
campus. One-sample t-test analysis revealed that mice which re-
ceived saline intra-hippocampus were able to recognized the
new object during STM (Fig. 3A; n = 9; t(8) = 2.455, P = 0.03) and
LTM test (Fig. 3B; n = 9; t(8) = 3.744, P = 0.005). The lower dose of
intra-hippocampus A-779 infusion (0.5ug/side) impaired both
STM (Fig. 3A; n = 9; t(8) = 1.737, P = 0.12) and LTM (Fig. 3B; n = 9;
t(8) = 1.07, P = 0.31) as well as the higher dose (2.5 ug/side) im-
paired STM (Fig. 3A; n = 9; t(8) = 0.757, P = 0.47) and LTM
(Fig. 3B; n = 9; t(8) = 1.742, P = 0.11). The one-way ANOVA revealed
a trend to difference between groups in the STM analysis
(F(2,24) = 3.325, P = 0.053). Otherwise, the analysis of LTM data
conﬁrmed the difference between saline and A-779 (2.5 ug/side)
group (F(2,24) = 5.362, P = 0.01). Our pharmacological data support
the idea that hippocampal Mas blockade or ablation impaired NOR
in mice.
3.5. AT1, but not AT2 blockade, prevents MasKo memory deﬁcit
Considering that Mas may inﬂuence the signal cascades acti-
vated by the Ang II/AT1 axis trough heterooligomerization withI) for 1.5 h (STM) and 24 h (LTM) after training tests in the NOR task. FVB/N (n = 10)
k. FVB/N (n = 10) show signiﬁcantly higher preference for the object located in a new
fect.
Fig. 3. Infusion of Mas antagonist, A-799, into the CA1 region of the dorsal hippocampus, blocks consolidation of NOR memory. Recognition indexes for STM (A) and (B) LTM
in the NOR task. (C) Composite of infusions sites aimed at the CA1-hippocampus and photomicrograph of guide cannulae placement in dorsal CA1 of the hippocampus. Values
are mean ± SEM. #P < 0.01.
Fig. 4. The pre-training blockade of AT1 receptors prevents the NOR impairment
expression in the MasKo mice. Recognition indexes of FVB/N and MasKo in the (A)
STM and (B) LTM tests. Saline (SAL); losartan (LOS) and PD123319 (PD). Values are
mean ± SEM. #Indicates difference from SAL group in the same genotype (P < 0.001)
and a indicates difference from SAL group in the same genotype (P < 0.05).
118 T.L.N. Lazaroni et al. / Neurobiology of Learning and Memory 97 (2012) 113–123AT1 receptor (Kostenis et al., 2005), we decided to evaluate the
participation of the AT1, as well as the AT2 receptors, on the mem-
ory impairment observed in MasKo. To do so, we blocked these
receptors by giving losartan and PD123319, speciﬁc antagonists
of AT1 and AT2 receptors, respectively, before the initiation of
the task.
Initially, we evaluated the inner group performance by compar-
ing the recognition index with the value of 0.5 (one-sample t-test)
to verify if there was a preference for one given object. The analysis
of the STM test revealed that FVB/N mice (white bars, Fig. 4A) were
able to recognize the new object after saline (SAL: t(6) = 7.909;
P = 0.0002), losartan (LOS: t(6) = 9.953, P < 0.0001) or PD123319
(PD: t(5) = 13.25, P < 0.0001) administration. MasKo mice (gray
bars, Fig. 4A) were unable to recognize the new object after saline
(SAL: t(6) = 0.366, P = 0.726) or PD123319 (PD: t(9) = 1.144,
P = 0.282), but their memory deﬁcit was completed abolished by
the pre-training administration of losartan (LOS: t(7) = 13.14,
P < 0.0001). Since the two-way ANOVA revealed an interaction be-
tween the factors, genotype and treatment (F(2,39) = 27.88,
P < 0.0001), we further analyzed the factors separately. The one-
way ANOVA showed that both drugs diminished the recognition
index of the FVB/N mice comparing to the saline group
(F(2,19) = 10.25, P = 0.001). The comparison between treatments
in the MasKo showed that LOS was different from the SAL and
PD groups (F(2,24) = 23.89, P < 0.0001). We also found a statistical
difference between genotypes in the saline (t(12) = 4, P = 0.001),
losartan (T(13) = 4.97, P = 0.003) and PD (t(14) = 2.17, P = 0.04)
groups.
The LTM analysis (Fig. 4B) revealed a similar pattern. All FVB/N
groups present intact ORM (SAL: t(6) = 5.418; P = 0.001; LOS:
t(6) = 4.959; P = 0.002; PD: t(5) = 5.501; P = 0.002). Again, MasKo
present ORM deﬁcit (SAL: t(6) = 0.85, P = 0.42) which was pre-
vented by losartan (LOS: t(7) = 4.949; P = 0.001), but not by
PD123319 administration (PD: t(9) = 0.28, P = 0.785). We found
an interaction between the factors genotype and treatment(F(2,39) = 3.45, P < 0.05), that we further analyzed separately.
There was no difference between treatments in the FVB/N mice
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losartan were different from the group which received saline and
PD (F(2,24) = 6.59, P = 0.005). There was a difference between
genotypes in the saline (t(12) = 2.27, P < 0.05) and PD groups
(t(14) = 2.95, P = 0.01), but not losartan groups (t(13) = 0.08,
P = 0.93).
As we administered losartan and PD123319 before the task be
initiated, the duration of object exploration during training brings
an additional information regarding drug’s effect on exploratory
activity. In fact, PD123319 increases the total time of objects explo-
ration in FVB/N [SAL = 31.1 ± 8.56 s; LOS = 29.39 ± 7.95 s;
PD = 50.91 ± 19.15 s] (F(2,25) = 7.36, p = 0.003) and MasKo
[SAL = 30.1 ± 13.37 s; LOS = 29.15 ± 8.41 s; PD = 55.75 ± 15.88 s]
(F(2,33) = 15.28, P < 0.0001), comparing to saline and losartan
(P < 0.05).
In conclusion, the results presented in Fig. 4 showed that the
blockade of AT1 and AT2 receptors has distinct effects on ORM.
In an animal with intact Ang-(1–7)/Mas axis, PD123319 and losar-
tan diminished the performance, without affecting memory in gen-
eral. However, if the Ang-(1–7)/Mas axis is altered by Mas ablation,
losartan has a promnesic effect, while PD123319 has no effect on
ORM of MasKo mice.3.6. MasKo hippocampus presents high levels of Ang-(1–7)
We next investigated the consequences of Mas ablation on the
brain renin–angiotensin system components. We choose to quan-
tify, in the hippocampus, the principal activator of Mas, Ang-
(1–7), and its main precursors, Ang I and Ang II, by RIA.
Our results demonstrated that there was no difference between
genotypes regarding Ang I (t(9) = 0.048, P = 0.96) and Ang II
(t(7) = 0.06, P = 0.94) concentrations. However, the concentration
of Ang-(1–7) in the whole hippocampus from MasKo is higher in
comparison to FVB/N mice (t(8) = 2.81, P = 0.02) (Fig. 5A). We also
measured the Ang-(1–7) level in the CA1 area of the hippocampus.
The results presented in the Fig. 5B reveal that MasKo mice have
higher levels of Ang-(1–7) compared to FVB/N mice in the CA1 area
(t(6) = 2.3, P = 0.05).4. Discussion
It was demonstrated previously that MasKo mice, on the mixed
129/C57BL/6 genetic background, present higher anxiety com-
pared to the controls, but no alterations were found in the Morris
Water Maze task (Walther et al., 1998). Here we showed no differ-
ences between genotypes regarding anxiety and to further analyze
the Ang-(1–7)/Mas axis modulation on memory, we chose three
different hippocampus-dependent tasks and the object recognition
was the only one affected by Mas ablation in the FVB/N geneticFig. 5. Mas ablation increases the Ang-(1–7) levels in the whole hbackground. Furthermore, the post-training infusion of A-779, a
speciﬁc antagonist of Mas, directly on CA1 area of the hippocam-
pus of FVB/N mice, impaired the consolidation of object memory.
Thus, both genetic ablation and pharmacological blockade of Mas
impair ORM, showing clearly that the integrity of the Ang-(1–7)/
Mas axis is required for the expression of this kind of episodic-like
memory.
Although our behavioral assessment results show no evidence
for motor strength, sensory perception or visual system impair-
ment; caution must be taken before stating that there is no behav-
ioral impairment in MasKo mice that could interfere with the
interpretation of results from the memory tasks presented in this
work. Nevertheless, pre-training data for each cognitive task eval-
uated, reinforces the hypothesis that there is no impediment of
MasKo mice executing the task other than the cognitive aspect
being tested. For example, in the Y-maze, both genotypes had sim-
ilar spontaneous alternation behavior (Fig. 1B) and similar percent-
age of entrances in the maze’s arms, suggesting proper exploratory
behavior (Fig. 1C). If MasKo presented motor impairments, the
exploration of the maze would most likely be compromised, but
it was not. The same rational can be used for the plus maze evalu-
ation tests. The mutants did not present either anxyolitic or anxi-
ogenic behavior (Fig. 1D), and no difference between genotypes
was found regarding entries in the open arms (Fig. 1E). Altogether
these results suggest that the Mas ablation does not compromise
exploratory activity in the mice. In addition, results from object
recognition tasks also show no evidence of exploratory behavior
impairments: since the time exploring the objects during the train-
ing session shows no statistical difference between MasKo and
control FVB/N. In fact, the only observable deﬁcit of MasKo mice
in relation to controls was within the test session during a new ob-
ject presentation task.
The declarative episodic memory provides us with data on
what, when and where particular event occurred. In animals, we
can evaluate a similar, but not necessarily equal, kind of declara-
tive-like memory through the object recognition tasks (Dere
et al., 2005, 2007). The consolidation of long-term object recogni-
tion memory requires hippocampal mRNA translation (Myskiw
et al., 2008) and protein synthesis (Rossato et al., 2007), which in
fact is similar to the inhibitory avoidance memory (IAM) consolida-
tion (Cohen-Matsliah, Motanis, Rosenblum, & Barkai, 2010;
Izquierdo, Cammarota, Medina, & Bevilaqua, 2004). However,
ORM is formed based on the spontaneous tendency of animals to
explore novelty and induces only low levels of emotional arousal
(Roozendaal, Okuda, de Quervain, & McGaugh, 2006), while IAM
is a classical emotionally arousing training task (Ferry, Roozendaal,
& McGaugh, 1999; Introini-Collison, Miyazaki, & McGaugh, 1991).
Thus, it seems that tasks with higher degree of emotional relevance
are less sensitive to Ang-(1–7)/Mas axis modulation. This idea is
partially supported by the fact that Ang-(1–7) infusion into CA1ippocampus (A) and in the CA1 area (B). n = 4–6, ⁄P < 0.001.
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memory (Bonini et al., 2006). Our results demonstrated that Mas
ablation compromises both STM and LTM in the novel object rec-
ognition task. As we submitted the same animal to the STM and
latter to the LTM evaluation protocol, we have to consider the pos-
sibility that one test could be interfering with the other. Our results
do not preclude an interference of the STM protocol in the consol-
idation/storage of the familiar object, presented twice, that might
affect the behavioral outcome of the NOR LTM task. In blunt terms,
there is no evidence in literature, that we know of, that conclu-
sively dissociates the mechanisms underlying STM and LTM, in
the NOR paradigm, if the same animal is used for evaluating both
types of memory. However, taking in consideration that (1) we
use distinct objects as the new element when evaluating both
types of memory (i.e. one novel object presented during STM is dif-
ferent than the novel object presented during LTM evaluation) and
(2) that the familiar object is identical for both tasks; one would
expect a consolidation of the familiar object memory during STM
evaluation and, consequently, an even better behavioral response
during the LTM evaluation (i.e. with an even higher percentage
of time spent in the novel object). This did not occur, which rein-
forces the LTM impairment interpretation of data, even more so
if partially compensated by a possible consolidation during the
STM protocol. Accordingly, the intra-hippocampal injection of A-
779, immediately after training, statistically impaired LTM.
Although differences were not statistically signiﬁcant, the effect
of A-779 in STM was similar to that observed in MasKo mice.
Concerning our experimental ﬁndings as to why MasKo mice
are able to acquire and maintain the avoidance response associated
with the IA task but not the declarative-like memory induced by
the OR paradigm, our methodological approach does not directly
address the speciﬁc mechanisms and differential involvement of
the Ang-(1–7)/Mas axis in the neural substrates speciﬁc to either
memory task. Nevertheless, it is possible to hypothesize on the rea-
sons for this apparent discrepancy. The OR memory is based on the
animal’s spontaneous exploratory activity, with no obvious aver-
sive component. Quite differently, IA memory relies on the associ-
ation between an action (step-down the platform) and noxious
stimulus (shock delivery in the paws). Thus, IA memory has to ac-
count for the innate interference in the behavioral response that is
associated with the processing of noxious stimulation. Another
hypothesis is that an overall hypersensitivity of MasKo mice to
noxious stimulus could be compensating for memory deﬁcits. It
has been showed that Mas-related G-protein–coupled receptors
(Mrgprs) are expressed on nociceptive, nonpeptidergic sensory
neurons in the dorsal root ganglia (Dong, Han, Zylka, Simon, &
Anderson, 2001; Lembo et al., 2002). Interestingly, a knockout
mouse line, where 12 Mrgprs genes were deleted, showed pro-
longed mechanical and thermal pain hypersensitivity after hind
paw inﬂammation (Guan et al., 2010). Based on this, it is possible
that MasKo performance in the IA task is a result of an exacerbated
associative response to the shock, rather than an intact fear-related
memory. However, since we did not measure pain threshold in
MasKo mice, this explanation is merely speculative, pending data
from ongoing experiments.
Interestingly, PD123319 administration before training pro-
duced an increase in the object exploration time, independently
of the genotype. Recently, it was demonstrated a positive correla-
tion between the amount of object exploration during the training
and the performance of the rats on the test session (Albasser,
Davies, Futter, & Aggleton, 2009). Then, if the increase in the object
exploration predicts memory enhancement, it should be expected
a better performance of both genotypes under PD1234319 pres-
ence, but, in fact, we observed the opposite. The drug diminished
the performance of FVB/N, without being amnesic and has no effect
on MasKo mice memory, which is originally impaired. Thus, itcould be assumed that the effect of PD123319 on object explora-
tion time is unrelated to memory and probably independent of
Ang-(1–7)/Mas axis functionality in the hippocampus. We also
found that losartan and PD123319 diminished the performance
of FVB/N mice on STM test, without affecting memory in general.
As we administered both drugs peripherally, it is possible that
other structures than the hippocampus are being affected by the
drugs to generate the behavior effects.
We also demonstrated that the blockade of AT1, by losartan,
rescue the memory deﬁcit observed in MasKo mice. Importantly,
this promnesic effect was exclusive for animals with Mas ablation
and was not a consequence of differences in the object exploration
time during the training. The classical Ang II effects on memory
and synaptic plasticity through AT1 receptors activation are con-
troversial. While some authors demonstrated a promnesic effect
(Fogari et al., 2003; Tota et al., 2009), others show no effect (Bonini
et al., 2006; Kerr et al., 2005) or even a negative modulation
(Denny et al., 1991; Wayner, Polan-Curtain, & Armstrong, 1995).
Indeed, the divergent signaling pathways used by AT1 receptor
may have different roles in the array of behaviors induced by
Ang II (Daniels, Yee, Faulconbridge, & Fluharty, 2005). Thus, diver-
gent intracellular signals from a single receptor type can give rise
to distinct behavioral phenomena. According, our results showed
that losartan administration prior training did not alter the object
exploration time in both genotypes, though decrease FVB/N perfor-
mance in the NOR. However, the losartan effect on MasKo was
opposite, it ameliorates the MasKo memory.
The fact that the memory deﬁcits observed in MasKo mice are
reversed with losartan strongly suggests that Ang-(1–7), also
shown to have increased concentration in MasKo hippocampus,
is probably exerting a deleterious effect through non-speciﬁc afﬁn-
ity to AT1 receptors. Nevertheless, such rational must be viewed
with caution. The promensic effect on MasKo, especially consider-
ing that losartan was administered peripherally, could be due to
Ang II tonic modulation on other areas. In physiological situations,
Ang II activates AT1 to induce a cascade of intra-neuronal signaling
events that ultimately leads to changes in membrane potential and
an increase in neuronal ﬁring (reviewed by Sumners, Fleegal, &
Mingyan, 2002). The activation of neurons in cardiovascular con-
trol brain regions results in stimulation of the sympathetic nervous
system, which mediates, at least partly, the cardiovascular compli-
cations associated with hypertension and heart failure (Carlson &
Wyss, 2008; Liu, Gao, Roy, Cornish, & Zucker, 2006). Interestingly,
MasKo in the FVB/N background exhibited higher blood pressures
compared to the control (Alenina et al., 2008) with a possible auto-
nomic balance shifted in favor of the sympathetic tone (reviewed
by Alenina et al., 2008). In fact, the release of norepinephrine
(NE) by the sympathetic nervous system plays an integral role in
regulating processes involved in learning and memory (Holscher,
1999; Morilak et al., 2005; Roozendaal et al., 2006). In contrast,
sustained exposure to NE can have detrimental effects on cognition
(de Kloet, Oitzl, & Joels, 1999; McEwen & Sapolsky, 1995). Taken
altogether, these results sprout an alternative idea regarding the
positive effect of losartan on MasKo ORM task performance; which
could be reducing the endogenously high sympathetic tone and, by
doing so, allowing the memory expression of MasKo mice to
normalize.
It has been demonstrated that Mas interacts with AT1 receptor
and inhibit the actions of Ang II, thus being a physiological antag-
onist of AT1 receptor (Kostenis et al., 2005; Sampaio, Henrique de
Castro, Santos, Schiffrin, & Touyz, 2007). Then, it is possible that in
the absence of Mas, the antagonism exerted by this receptor is no
longer active, which could be detrimental for NOR memory. Fur-
thermore, we demonstrated that MasKo hippocampus present high
levels of Ang-(1–7) and it is well known that Ang-(1–7) can acti-
vate AT1 receptors nonspeciﬁcally (Rowe et al., 1995). In this
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level of the Ang(1–7) could be converging to an exacerbate AT1
activation, with deleterious effects on ORM. In fact, Hellner and
coworkers (2005) demonstrated that when the AT1 receptors were
blocked by losartan in MasKo mice slices, Ang-(1–7) did not show
its inhibitory effect on CA1-LTP. The authors suggested that Ang-
(1–7)-induced suppression of LTP in MasKo mice was mediated
by a non-speciﬁc action of Ang-(1–7) on AT1 receptors.
Our results strongly suggest an interaction between Mas and
AT1 on the modulation of NOR memory, but are limited regarding
the mechanism involved in this interaction. However, we can spec-
ulate that the crosstalk between both receptors could be happen-
ing, at least partially, via the modulation of the intracellular
pathways dependent of the nitric oxide (NO) production, which
is essential for NOR memory (Furini et al., 2010). In fact, Mas acti-
vation induces the release of NO (Sampaio et al., 2007; Dias-
Peixoto et al., 2009; Feng et al., 2010) and, recently, it was demon-
strated that Ang-(1–7) is capable of increasing nNOS-derived NO
levels, in catecholaminergic neurons, through activation of Mas
(Yang, Yin, Li, Zimmerman, & Schultz, 2011). Accordingly, MasKo
exhibited impaired endothelial function, decrease NO production
and lower endothelial NO synthase expression (Alenina et al.,
2008).
In summary, the absence of the Ang-(1–7)/Mas axis effect on
attenuate the actions of the AngII/AT1R pathway, through stimula-
tion of nitric oxide release (reviewed by Xia and Lazartigues, 2008),
is probably absent in the MasKo, which could be detrimental to
memory.5. Conclusions
The ﬁndings of the present study showed that the disruption of
the Ang-(1–7)/Mas axis causes speciﬁc memory deﬁcit in the ob-
ject recognition task and increases Ang-(1–7) level in the whole
hippocampus, as well as in the CA1 area. Furthermore, it is possible
that the memory deﬁcit observed in MasKo mice is due to AT1
receptors activation. These ﬁndings suggest, for the ﬁrst time,
Ang-(1–7)/Mas axis as an important modulator of object recogni-
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